SRX sierra rutile holdings limited

For HCC - and potentially even for metastatic liver disease......

  1. 820 Posts.
    lightbulb Created with Sketch. 69
    For HCC - and potentially even for metastatic liver disease... the biggest risk in the future to SRX is OSL, in view of the method of administration. The OSL patent allows for Yittrium to be incorporated but from memory only with P32.

    Percutaneous administration is advantageous, but SRX is still years ahead of OSL.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.